1. Home
  2. WVVI vs GBIO Comparison

WVVI vs GBIO Comparison

Compare WVVI & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVVI
  • GBIO
  • Stock Information
  • Founded
  • WVVI 1983
  • GBIO 2016
  • Country
  • WVVI United States
  • GBIO United States
  • Employees
  • WVVI N/A
  • GBIO N/A
  • Industry
  • WVVI Beverages (Production/Distribution)
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • WVVI Consumer Staples
  • GBIO Health Care
  • Exchange
  • WVVI Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • WVVI 31.0M
  • GBIO 29.2M
  • IPO Year
  • WVVI N/A
  • GBIO 2020
  • Fundamental
  • Price
  • WVVI $5.74
  • GBIO $0.38
  • Analyst Decision
  • WVVI
  • GBIO Strong Buy
  • Analyst Count
  • WVVI 0
  • GBIO 4
  • Target Price
  • WVVI N/A
  • GBIO $7.33
  • AVG Volume (30 Days)
  • WVVI 5.6K
  • GBIO 508.8K
  • Earning Date
  • WVVI 05-13-2025
  • GBIO 05-07-2025
  • Dividend Yield
  • WVVI N/A
  • GBIO N/A
  • EPS Growth
  • WVVI N/A
  • GBIO N/A
  • EPS
  • WVVI N/A
  • GBIO N/A
  • Revenue
  • WVVI $38,520,945.00
  • GBIO $24,556,000.00
  • Revenue This Year
  • WVVI N/A
  • GBIO N/A
  • Revenue Next Year
  • WVVI N/A
  • GBIO $10.90
  • P/E Ratio
  • WVVI N/A
  • GBIO N/A
  • Revenue Growth
  • WVVI N/A
  • GBIO 146.47
  • 52 Week Low
  • WVVI $3.17
  • GBIO $0.32
  • 52 Week High
  • WVVI $6.33
  • GBIO $4.34
  • Technical
  • Relative Strength Index (RSI)
  • WVVI 41.00
  • GBIO 44.36
  • Support Level
  • WVVI $5.71
  • GBIO $0.35
  • Resistance Level
  • WVVI $6.09
  • GBIO $0.42
  • Average True Range (ATR)
  • WVVI 0.17
  • GBIO 0.03
  • MACD
  • WVVI -0.02
  • GBIO 0.00
  • Stochastic Oscillator
  • WVVI 42.67
  • GBIO 31.54

About WVVI Willamette Valley Vineyards Inc.

Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: